The Saudi Food and Drug Authority (SFDA) has emphasized the importance of obtaining approval before advertising products under its supervision, to ensure their safety and protect public health.
The Saudi Food and Drug Authority (SFDA) confirmed the growth in registration and licensing outcomes during the first quarter of 2024, attributing this progress to the support and empowerment provided by the SFDA to investors in the sectors under its supervision.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, led the SFDA delegation at the 8th Shenzhen Food Safety Forum today. The forum is taking place from November 5th to 6th, 2024, in Shenzhen, China.
The forum, organized by the Shenzhen Institute of Standards and Technology, was inaugurated by Cai Yingquan, Director-General of Market Regulation Bureau of Shenzhen Municipality.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, met on Monday with Mr. Wang Bing, the Director of the Shenzhen Institute for Drug Control (SZIDC), at the SZIDC headquarters in Shenzhen, China.
The meeting focused on strengthening cooperation through joint research projects, knowledge sharing, and best practices.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, was briefed yesterday, Saturday, on advanced manufacturing technologies for biological and genetic medicines at a specialized factory in Tianjin, China. These techniques are considered modern innovations in the medical field, aimed at providing treatments for many incurable diseases.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, met with several companies in the food, pharmaceutical, and medical product industries. H.E. Mr. Abdulrahman Al-Harbi, Saudi Arabia’s Ambassador to China; Mr. Wang Maochun, Vice President of the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE); and Ms. Li Xiangying, Chairman of the China Council for the Promotion of International Trade (CCPIT), attended the meeting.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, led the SFDA delegation on an official visit to the People's Republic of China to sign a Memorandum of Understanding with China’s National Medical Products Administration (NMPA) and to participate in the 8th Shenzhen Food Safety Forum.
Dr. Aljadhey visited several counterpart authorities today, accompanied by H.E. Mr. Abdulrahman Al-Harbi, Saudi Arabia’s Ambassador to China.
The Saudi Food and Drug Authority (SFDA) hosted the 2024 Research Day event today, marking its fourth edition. The event took place at the SFDA headquarters in Riyadh and was attended by the Chief Executive Officer, H.E. Dr. Hisham S. Aljadhey, along with several officials. This initiative aligns with SFDA's strategic plan to foster a research-driven, innovative, and robust regulatory environment, establishing itself as a preeminent global authority dedicated to promoting and protecting public health through scientific principles.
H.E. Dr. Hisham S. Aljadhey, Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), launched an initiative today, Wednesday, aimed at developing diagnostic laboratory equipment and advancing 3D printing in hospitals. The launch was made at the SFDA’s pavilion participating in the Global Health Exhibition 2024 in Riyadh, which concludes today.
The Saudi Minister of Health and Chairman of the Board of Directors of the Saudi Food and Drug Authority (SFDA), H.E. Fahd bin Abdurrahman Al-Jalajel, launched a licensing initiative today for medical software in digital health. This initiative facilitates the use of software for diagnosis, treatment, and medical decision-making. The launch ceremony, held during the Global Health Exhibition 2024 in Riyadh from October 21 to 23, was attended by the CEO of the SFDA, H.E. Dr. Hisham S. Aljadhey.
